Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-12-000192
Filing Date
2012-09-14
Accepted
2012-09-14 15:27:46
Documents
11
Period of Report
2012-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq2july3112w0.htm 10-Q 250650
8 EXHIBIT 31.1 neurokinesection302certceoq2.htm EX-31 7739
9 EXHIBIT 31.2 neurokinesection302certcfoq2.htm EX-31 7823
10 EXHIBIT 32.1 neurokinesection906certceoq2.htm EX-32 5672
11 EXHIBIT 32.2 neurokinesection906certcfoq2.htm EX-32 5662
  Complete submission text file 0001511164-12-000192.txt   2429546

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT neukf-20120731.xml EX-101.INS 325447
3 XBRL TAXONOMY EXTENSION SCHEMA neukf-20120731.xsd EX-101.SCH 43349
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20120731_cal.xml EX-101.CAL 18774
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20120731_def.xml EX-101.DEF 122549
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20120731_lab.xml EX-101.LAB 152466
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20120731_pre.xml EX-101.PRE 121701
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 121092576
SIC: 2834 Pharmaceutical Preparations